PMID- 35225678 OWN - NLM STAT- MEDLINE DCOM- 20220316 LR - 20220316 IS - 1945-0257 (Electronic) IS - 1945-0257 (Linking) VI - 26 IP - 2 DP - 2022 Feb TI - Bacterial Identification and Visualization of Bacterial Biofilms Adjacent to Fracture Sites After Internal Fixation. PG - 70-80 LID - 10.1089/gtmb.2019.0225 [doi] AB - Objectives: The primary aims of this study were to determine if any correlation exists in cases of fracture fixation among: (1) bacterial profiles recovered from the instrumentation and adjacent tissues; (2) the type of orthopedic injury; and (3) the clinical outcome-union versus nonunion. A secondary goal was to compare culture and molecular diagnostics for identifying the bacterial species present following fracture fixation. Design: Single-institution, prospective case-control cohort study. Setting: Single level 1 trauma center. Patients: Forty-nine bony nonunion cases undergoing revision internal fixation and 45 healed fracture controls undergoing removal of hardware. Intervention: Bacterial infection was detected by standard microbial culture methods and by a pan-eubacterial domain, molecular diagnostic (MDx) assay. Confirmation of culture and MDx results was achieved with bacterial ribosomal 16S rRNA fluorescence in situ hybridization (FISH) to visualize bacterial biofilms. Main Outcome Measurements: MDx and microbial culture methods results were the primary study outcomes. Results: Ninety-four percent of the nonunion cohort and 93% of the union cohort had bacteria detected by the MDx. Seventy-eight percent of the nonunion cases and 69% of the controls were culture negative, but MDx positive. Although no significant differences in bacterial composition were observed between the cases and controls, differences were observed when cases were divided by comorbidities. Conclusion: The MDx is more sensitive than microbial culture in detecting bacterial presence. The lack of significantly different findings with regard to bacterial profile identified between the cases and controls suggests that host factors and environmental conditions are largely responsible for determining if bony union will occur. Level of Evidence: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence. FAU - Palmer, Michael P AU - Palmer MP AD - The Christ Hospital Network, Cincinnati, Ohio, USA. FAU - Altman, Daniel T AU - Altman DT AD - Department of Orthopedics, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. FAU - Altman, Gregory T AU - Altman GT AD - Department of Orthopedics, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. FAU - Sewecke, Jeffrey J AU - Sewecke JJ AD - Department of Orthopedics, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. FAU - Saltarski, Courtney AU - Saltarski C AD - Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA. FAU - Nistico, Laura AU - Nistico L AD - Center of Excellence in Biofilm Research Genomic Sciences, Allegheny Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. FAU - Melton-Kreft, Rachael AU - Melton-Kreft R AD - Center of Excellence in Biofilm Research Genomic Sciences, Allegheny Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. FAU - Hu, Fen Z AU - Hu FZ AD - Center for Biofilms and Surgical Infections, Center for Genomic Sciences, and Center for Advanced Microbial Processing, Institute of Molecular Medicine and Infectious Disease, Philadelphia, Pennsylvania, USA. AD - Departments of Microbiology and Immunology, and Otolaryngology Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. FAU - Ehrlich, Garth D AU - Ehrlich GD AD - Center for Biofilms and Surgical Infections, Center for Genomic Sciences, and Center for Advanced Microbial Processing, Institute of Molecular Medicine and Infectious Disease, Philadelphia, Pennsylvania, USA. AD - Departments of Microbiology and Immunology, and Otolaryngology Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. LA - eng PT - Journal Article PL - United States TA - Genet Test Mol Biomarkers JT - Genetic testing and molecular biomarkers JID - 101494210 RN - 0 (RNA, Ribosomal, 16S) SB - IM MH - Bacteria/genetics MH - Biofilms MH - Case-Control Studies MH - *Fractures, Ununited/diagnosis/microbiology/surgery MH - Humans MH - In Situ Hybridization, Fluorescence MH - RNA, Ribosomal, 16S/genetics MH - Retrospective Studies MH - Treatment Outcome OTO - NOTNLM OT - FISH OT - bacteria OT - bony nonunion OT - infected implant OT - molecular diagnostics OT - tissue culture EDAT- 2022/03/01 06:00 MHDA- 2022/03/17 06:00 CRDT- 2022/02/28 12:14 PHST- 2022/02/28 12:14 [entrez] PHST- 2022/03/01 06:00 [pubmed] PHST- 2022/03/17 06:00 [medline] AID - 10.1089/gtmb.2019.0225 [doi] PST - ppublish SO - Genet Test Mol Biomarkers. 2022 Feb;26(2):70-80. doi: 10.1089/gtmb.2019.0225.